CMSC 2022

CMSC 2022

Multiple sclerosis MRI protocol: consensus recommendations and clinician guide 1:45
Multiple sclerosis MRI protocol: consensus recommendations and clinician guide
David Li • 21 Jun 2022
The cost of multiple sclerosis 3:13
The cost of multiple sclerosis
Bari Talente • 16 Jun 2022
Efficacy of inebilizumab in patients with NMOSD with Fc receptor III-A polymorphisms 5:12
Efficacy of inebilizumab in patients with NMOSD with Fc receptor III-A polymorphisms
Bruce Cree • 13 Jun 2022
The importance of standardized MRI protocols in diagnosing and monitoring MS 2:56
The importance of standardized MRI protocols in diagnosing and monitoring MS
David Li • 21 Jun 2022
An outlook on the future therapeutic landscape of MS 4:38
An outlook on the future therapeutic landscape of MS
Ahmed Obeidat • 15 Jun 2022
How is advocacy influencing MS healthcare? 4:12
How is advocacy influencing MS healthcare?
Bari Talente • 16 Jun 2022
The role of patient-centered approaches in equitable MS care 2:51
The role of patient-centered approaches in equitable MS care
Mitzi Joi Williams • 17 Jun 2022
Consistent efficacy of inebilizumab across newly presenting and previously treated NMOSD cases 1:48
Consistent efficacy of inebilizumab across newly presenting and previously treated NMOSD cases
Bruce Cree • 13 Jun 2022
Ensuring that standardized MRI protocols are widely used in MS care 4:24
Ensuring that standardized MRI protocols are widely used in MS care
David Li • 21 Jun 2022
BTK inhibitors in treating the spectrum of MS 4:22
BTK inhibitors in treating the spectrum of MS
Ahmed Obeidat • 15 Jun 2022
Achieving patient centered care in daily practice 1:05
Achieving patient centered care in daily practice
Mitzi Joi Williams • 17 Jun 2022
The complex healthcare landscape of MS 2:11
The complex healthcare landscape of MS
Bari Talente • 16 Jun 2022
Key considerations for clinicians treating NMOSD 2:27
Key considerations for clinicians treating NMOSD
Bruce Cree • 13 Jun 2022
Steps towards equity in MS care for minority populations 2:26
Steps towards equity in MS care for minority populations
Mitzi Joi Williams • 17 Jun 2022
Personalized and precision therapy in multiple sclerosis 2:58
Personalized and precision therapy in multiple sclerosis
Ahmed Obeidat • 15 Jun 2022
S1P receptor modulators in the treatment of MS 5:43
S1P receptor modulators in the treatment of MS
Bruce Cree • 13 Jun 2022
The content of VJNeurology is intended for healthcare professionals